Free Trial
NYSEARCA:SBIO

ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News

$36.06
-0.35 (-0.96%)
(As of 09/6/2024 ET)
Today's Range
$35.71
$36.68
50-Day Range
$32.60
$38.74
52-Week Range
$23.21
$38.80
Volume
3,409 shs
Average Volume
11,152 shs
Market Capitalization
$115.40 million
Assets Under Management
$110.03 million
Dividend Yield
0.21%
Net Expense Ratio
0.50%
SBIO stock logo

About ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.

SBIO Stock Price History

SBIO ETF News Headlines

Why Biotech ETFs Are Beating the Market
ALPS Medical Breakthroughs ETF (^SBIO-IV)
Perfect Crypto Buying Opportunity for 50 Cents
When cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious Bank
ALPS Medical Breakthroughs ETF (SBIO)
How ETF Investors Can Take Advantage Of Deal Activity
Perfect Crypto Buying Opportunity for 50 Cents
When cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious Bank
Biotech ETF SBIO’s Momentum Strong to End 2023
See More Headlines
Receive SBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
ALPS
Fund Name
ALPS Medical Breakthroughs ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:SBIO
Inception Date
12/31/2014
Fund Manager
Ryan Mischker, Andrew Hicks
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S-Network Medical Breakthroughs Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
106

Fund Statistics

Assets Under Management
$110.03 million
Average Daily Volume
$4,618.20
Discount/Premium
-0.02%

Administrator, Advisor and Custodian

Administrator
ALPS Fund Services, Inc.
Advisor
ALPS Advisors, Inc.
Custodian
State Street Bank and Trust Company
Distributor
ALPS Portfolio Solutions Distributor, Inc.
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
GTS

Options

Optionable
N/A
Short Interest
1,000 shs

Miscellaneous

Beta
1.08
Creation Unit
50,000
Creation Fee
$500.00
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

ALPS Medical Breakthroughs ETF Expenses

TypeSBIOHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.56%0.55%0.51%0.52%
Other Expenses0.00%0.33%0.49%0.58%0.54%
Total Expense0.50%0.71%0.71%0.74%0.71%
Fee Waiver0.00%-0.45%-0.53%-0.68%-0.58%
Net Expense0.50%0.61%0.61%0.58%0.59%

ALPS Medical Breakthroughs ETF (SBIO) Holdings & Exposure


SBIO ETF - Frequently Asked Questions

How have SBIO shares performed this year?

ALPS Medical Breakthroughs ETF's stock was trading at $32.94 at the start of the year. Since then, SBIO stock has increased by 9.5% and is now trading at $36.0628.
View the best growth stocks for 2024 here
.

Who are ALPS Medical Breakthroughs ETF's major shareholders?

ALPS Medical Breakthroughs ETF's top institutional investors include Griffin Asset Management Inc. (0.72%), Ridgewood Investments LLC (0.63%), Financial Advocates Investment Management (0.24%) and Retirement Planning Co of New England Inc. (0.23%).

How do I buy shares of ALPS Medical Breakthroughs ETF?

Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of ALPS Medical Breakthroughs ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ALPS Medical Breakthroughs ETF investors own include Micron Technology (MU), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Johnson & Johnson (JNJ), Novavax (NVAX) and

This page (NYSEARCA:SBIO) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners